The detection and treatment of cancer for patients without health insurance is extremely complex because it relies on a patchwork of programs for service delivery. “These gaps create inequity across the system by age, sex, and site,” says Dr. Veronica X. Vela, Senior Director for Healthcare Access. “Currently, there are no dedicated resources to oversee and improve the network of safety-net programs that constitute the continuum of care. Lack of dedicated oversight and facilitated coordination compromises the safety net's ability to diagnose and treat patients early, exacerbating healthcare costs.”
PCC’s cancer prevention and detection program leverages multiple funding sources and partnerships to provide screening for breast, cervical, and colorectal cancer. Among them is the Breast and Cervical Cancer Program (BCCP), which provides direct screening for breast and cervical cancers through a combination of state and federal funding. Funds for BCCP come from the Centers for Disease Control and Prevention Award – 93.898 Cancer Prevention and Control for State, Territorial, and Tribal Organizations and MDH Center for Cancer Prevention and Control. Although it is currently the most resourced program within PCC, BCCP operates at only two partner health centers, with participation fluctuating due to its administrative requirements.
Across cancer screening types and funders, there are persistent challenges. Many of them are structural: patients need more navigation support across a fragmented service landscape and social access barriers, Montgomery Cares mammogram eligibility has not kept pace with US Preventive Services Task Force screening guidelines, and funding is insufficient for the administrative and operational responsibilities across screening programs.
Even in the face of these challenges, PCC continues to make meaningful strides. The program team established a partnership with Exact Sciences to provide free Cologuard colon cancer screening tests and supported rollout across five partner health centers . This reduced barriers for Montgomery Cares patients and brought more than $120,000 in donated testing capacity to uninsured residents in just the first half of this year. A state audit commended strong PCC program performance in breast and cervical cancer screening services.
Better early detection is crucial amid a rising overall cancer burden among Montgomery Cares patients. Since 2021, the number of cancer care patients has more than doubled, from 114 to 264, and the number of hematology and oncology appointments required to support these patients has more than tripled. In FY25, PCC coordinated 450 cancer care appointments, up from 139 in 2021. Where possible, PCC leverages grants from the Maryland Cancer Fund, a program of the MDH Center for Cancer Prevention and Control, to support treatment costs. An additional 31 colonoscopies were coordinated for patients who could not be served by the State-funded Cancer Crusade program, which was temporarily closed to new patients. While absolute numbers remain modest, the impact of access to cancer care for each patient is substantial.
“A dedicated navigator would ensure timely treatment for all patients and support patients moving from diagnosis to treatment,” explains Vela. “Currently this work is absorbed by the Project Access Clinical Lead, which takes time away from reviewing specialty care referrals for the broader Montgomery Cares population, slowing down access to specialty care for other patients.”
Given these obstacles, PCC has identified priorities to strengthen the continuum of cancer care for uninsured resident, including securing funding for program management, expanding breast cancer screening eligibility to women ages 40–44, and establishing patient navigation as a core program service.
PCC’s cancer prevention and screening program remains a vital resource for uninsured and underserved communities. “Despite funding gaps, fragmented services, and systemic barriers, PCC remains committed to early detection, equitable access, and continuous improvement,” says President and CEO Annice Cody, “ensuring every patient has the opportunity for timely, lifesaving cancer care.”
RSS Feed